Drugs

International group of experts develops an evidence-based clinical practice guideline (algorithm) for using metformin to prevent/treat antipsychotic-induced weight gain.

Health Canada has reviewed evidence on the link between glucagon-like peptide-1 (GLP-1) receptor agonists and suicide, self-harm and suicidal/self-harm ideation.

The fee, which is being implemented to pharmacies but not to prescribers, places unnecessary financial burdens on pharmacies, according to the CPhA.

A review of new launches, new indications, new dosage forms and Health Canada advisories.

As use becomes more widespread, understanding cannabinoid interactions with medications is essential for pharmacists and other healthcare providers.

A Health Canada safety review concludes that there is a possible link between statin (HMG-CoA reductase inhibitor) use and the risk of myasthenia gravis.

At Neighbourhood Pharmacies of Canada’s annual Specialty Pharmacy Summit, the message was clear. Community pharmacies should no longer feel excluded from the specialty pharmacy arena.

Pharmacists can play an important role in screening patients for hypothyroidism.